The novel approach of the medication represents a significant advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide619558.mdkblog.com/48182642/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment